Skip to main content

Peer Review reports

From: Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report

Original Submission
21 Aug 2020 Submitted Original manuscript
3 Jan 2021 Reviewed Reviewer Report - Hamouda Boussen
7 Jan 2021 Reviewed Reviewer Report - luigi cavanna
27 Jan 2021 Author responded Author comments - Caroline Chen
Resubmission - Version 2
27 Jan 2021 Submitted Manuscript version 2
28 Jan 2021 Reviewed Reviewer Report - Hamouda Boussen
9 Feb 2021 Reviewed Reviewer Report - luigi cavanna
14 Feb 2021 Author responded Author comments - Caroline Chen
Resubmission - Version 3
14 Feb 2021 Submitted Manuscript version 3
Publishing
18 Feb 2021 Editorially accepted
24 Apr 2021 Article published 10.1186/s13256-021-02748-y

You can find further information about peer review here.

Back to article page